What is JBIO's preferred stock?

JBIO (JBIO) reported preferred stock of $2K in Q3 2025.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

JBIO JBIO Preferred Stock

Preferred Stock at other companies

Travere Therapeutics, Inc.TVTX

$0—

AnaptysBio, Inc.ANAB

$0—

Cullinan Therapeutics, Inc.CGEM

$0—

Nektar TherapeuticsNKTR

$0—

Janux TherapeuticsJANX

$0—

Kymera TherapeuticsKYMR

$0—

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: JBIO’s 10-Q, filed November 14, 2025, on SEC EDGAR. View the filing →

Ask your AI about JBIO's preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's preferred stock?: JBIO (JBIO) reported preferred stock of $2K in Q3 2025.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.